The Board of Directors of Revolution Medicines, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Governance Documents
Committees Composition
| Director Name | Audit Committee | Compensation Committee | Nominating and Corporate Governance Committee | Research & Development Committee | Commercialization Committee |
|---|---|---|---|---|---|
| Liz McKee Anderson | Chairperson ofthe Compensation committee | Member ofthe Commercialization committee | |||
| Flavia Borellini, Ph.D. | Member ofthe Compensation committee | Chairperson ofthe Research & development committee | |||
| Alexis Borisy Lead Director | Member ofthe Compensation committee | Member ofthe Nominating and corporate governance committee | |||
| Frank Clyburn | Member ofthe Compensation committee | Member ofthe Nominating and corporate governance committee | Chairperson ofthe Commercialization committee | ||
| Mark A. Goldsmith, M.D., Ph.D. Chairman of the Board | |||||
| Sandra Horning, M.D. | Member ofthe Research & development committee | ||||
| Lorence Kim, M.D. | Chairperson ofthe Audit committee | Chairperson ofthe Nominating and corporate governance committee | |||
| Sush Patel | Member ofthe Audit committee | Member ofthe Commercialization committee | |||
| Thilo Schroeder, Ph.D. | Member ofthe Audit committee |
Legend
= Chairperson
= Member
= Lead Director
= Chairman of the Board